Caplin Point Laboratories Share Price Live

CAPLIPOINT

Small Cap | Pharmaceuticals

2033.10

+13.40(0.66%)

Live Caplin Point Laboratories Share Price Chart

Caplin Point Laboratories Performance

Days Range

Previous Close₹2,019.70
Open₹2,025
Volume84,406
Day's Range₹2,015.20 - ₹2,048.70
52W Range₹1,500.30 - ₹2,395.00
Market Cap₹15,441.40 Cr

Caplin Point Laboratories Fundamentals

ROCE(TTM)22.30
P/E Ratio (TTM)23.77
P/B Ratio4.31
Industry P/E33.71
Debt to EquityN/A
ROE17.88
EPS (TTM)84.36
Dividend Yield0.2
Book Value471.83
Face Value2
ROCE(TTM)22.30
P/E Ratio (TTM)23.77
P/B Ratio4.31
Industry P/E33.71
Debt to EquityN/A
ROE17.88
EPS (TTM)84.36
Dividend Yield0.2
Book Value471.83
Face Value2

Caplin Point Laboratories Financials

Jun 2025Sep 2025Dec 2025Mar 2026
Net Sales510.22534.04542.77600.16
Expenses348.75363.27372.36414.72
Profit before tax184.46201.00203.89213.44
Operating Profit150.76160.23165.86172.88
Net Profit150.76160.23165.86172.88
EPS in Rs20.1020.3221.5622.38

Caplin Point Laboratories Shareholding Pattern

Promoters
70.57%
Retail And Others
21.14%
Foreign Institutional Investors
6.15%
Domestic Institutional Investors
2.14%

About Caplin Point Laboratories

Incorporated in Apr.'90, Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders. The company came out with a public issue in Nov.'94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point. The company entered into a technical agreement with American Remedies, US, and Concord Laboratories, US, for specific products, with a 30% buyback arrangement. It also imports bio-technological products to market them in India. The company has established a trading branch in Nairobi, Kenya, to sell its products in East Africa. It has also established a warehouse in Miami, US, by entering into a marketing tie-up with Lockett Medical Corporation, US.

Parent Organisation
Indian Private
Managing Director
Sridhar Ganesan
Founded
1990
NSE Symbol
CAPLIPOINT

Caplin Point Lab Share Price History

ParticularsDetails
5-Year % change in Caplin Point Lab share price467.36%
5-Year Highest in Caplin Point Lab share price₹ 2641
5-Year Lowest in Caplin Point Lab share price₹ 305.1
1-Year % change in Caplin Point Lab share price43.3%
1-Year Highest in Caplin Point Lab share price₹ 2641
1-Year Lowest in Caplin Point Lab share price₹ 1225

Peer Comparison

StocksLTP (₹)Market Cap (cr)52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd1,782.2
2.10 (0.12%)
₹4,27,933.391,548.0 - 1,916.6View Stocks
Divis Laboratories Ltd6,623.0
26.50 (0.40%)
₹1,75,833.115,636.5 - 7,071.5View Stocks
Torrent Pharmaceuticals Ltd4,420.9
81.00 (1.87%)
₹1,49,548.893,132.7 - 4,712.9View Stocks
Cipla Ltd1,401.3
2.60 (0.19%)
₹1,13,154.891,165.7 - 1,673.0View Stocks
Zydus Lifesciences Ltd1,089.0
4.40 (0.41%)
₹1,09,568.82835.5 - 1,115.5View Stocks
Dr Reddys Laboratories Ltd1,278.2
10.70 (0.84%)
₹1,06,652.471,148.4 - 1,379.7View Stocks

Caplin Point Laboratories Latest News

Caplin Point Lab Ltd FAQs

Caplin Point Lab Ltd (CAPLIPOINT) share price as of June 5, 2026, on NSE is Rs 2033.1 (NSE) and Rs 2033.1 (BSE) on BSE.
Yes, You can buy Caplin Point Lab Ltd (CAPLIPOINT) shares by opening a Demat account with Angel One.
Caplin Point Lab Ltd (CAPLIPOINT) share can be bought through the following modes:
1. Direct investment: You can buy Caplin Point Lab Ltd (CAPLIPOINT) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Caplin Point Lab Ltd (CAPLIPOINT) shares.
Caplin Point is a pharmaceutical enterprise that was founded in 1990 which is a business of producing a variety of external applications such as ointments and creams.
P Vijayalakshmi, Paarthipan C C, Ashok Gorkey Partheeban, and Partheeban Vivek Siddarth are the major promoters of Caplin Point Laboratories.
Caplin Steriles, Argus Salud Pharma, Caplin Point Colombia S.A.S, Caplin Point Hong Kong, Caplin Onco and Caplin Point Pte Ltd are the Subsidiaries that come under Caplin Point Laboratories.
The market cap of Caplin Point Laboratories is Rs. 15441.40 Cr. as of 07/06/2026.
The P/E ratios of Caplin Point Laboratories is 23.77 as of 07/06/2026.
The PB ratios of Caplin Point Laboratories is 4.31 as of 07/06/2026.
Open Free Demat Account!
Join our 3.5 Cr+ happy customers